Back to PRLD
GOLDMAN SACHS GROUP INC → PRLD
GOLDMAN SACHS GROUP INC PRLD Position History
Prelude Therapeutics Incorporated • Healthcare
Quarters held
12
Latest value
$61K
Q3 2026
Peak value
$1.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $107K |
| Q1 2025 | $13K |
| Q2 2025 | $121K |
| Q3 2025 | $114K |
| Q4 2025 | $341K |
| Q4 2025 | $341K |
| Q1 2026 | $809K |
| Q2 2026 | $265K |
| Q2 2026 | $379K |
| Q3 2026 | $1.7M |
| Q3 2026 | $888K |
| Q3 2026 | $61K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $61K | 15.5K | — | — |
| Q3 2026 | $888K | 227.0K | — | — |
| Q3 2026 | $1.7M | 424.3K | — | — |
| Q2 2026 | $379K | 71.1K | — | — |
| Q2 2026 | $265K | 49.8K | — | — |
| Q1 2026 | $809K | 236.5K | — | — |
| Q4 2025 | $341K | 117.5K | — | — |
| Q4 2025 | $341K | 117.5K | — | — |
| Q3 2025 | $114K | 79.3K | — | — |
| Q2 2025 | $121K | 149.2K | — | — |
| Q1 2025 | $13K | 16.4K | — | — |
| Q1 2025 | $107K | 138.8K | — | — |
Other funds holding PRLD
$73.2M
$53.7M
$39.6M
$37.3M
$34.6M
$31.6M